Centers | ||
EU-OPENSCREEN | FDA Oncology Center of Excellence Project Catalyst | Presude Life Sciences |
EU-OPENSCREEN is a multinational, not-for-profit initiative, which
integrates high-capacity screening platforms and chemistry groups across
Europe. The aim of this initiative is to support individual scientists
interested in chemical biology... |
Providing a regulatory platform to connect scientific knowledge, creative insight, and medical professionals to foster early-stage product innovation |
Presude Lifesciences is an integrated drug discovery and development services organization led by biopharma professionals with global experience. Read morePresude is a research driven company with expertise in medicinal chemistry, custom synthesis and... |
Partnerships |
Events |
Jobs |
Sanofi and Joslin Diabetes Center to Develop New Drugs for Diabetic CareJoslin Diabetes Center a teaching and research affiliate of Harvard Medical School and Sanofi have entered into a partnership agreement to develop new drugs to treat diabetes. Under this collaboration, Sanofi will have the right to commercialize... View all JDRF & Novo Nordisk to Collaborate on Type 1 DiabetesJDRF and Novo Nordisk have entered into collaboration to develop new immunotherapies to treat Type 1 diabetes. The new partnership will be based out of Novo's newly opened Type 1 Diabetes R&D Center in Seattle. JDRF and Novo Nordisk will be... View all Takeda Partners with Florida Hospital & Sanford-Burnham in Obesity AreaTakeda Pharmaceuticals has entered into a collaboration with Florida Hospital and Sanford-Burnham Medical Institute to discover and develop new therapeutic approaches to treat obesity. The two collaboration agreement will involve Takeda providing... View all |
No EVENTS for listing |
No Job Posts |


